2. Amyotrophic lateral sclerosis Clinical trials / Disease details
Clinical trials : 645 / Drugs : 589 - (DrugBank : 163) / Drug target genes : 150 - Drug target pathways : 225
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00005766 (ClinicalTrials.gov) | May 2000 | 1/6/2000 | Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | Drug: Creatinine | National Center for Research Resources (NCRR) | NULL | Completed | 18 Years | 80 Years | Both | Phase 2 | United States |